Nanofarma Development Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Nanofarma Development General Information

Description

Provider of drug development services. The company specializes in oral drug delivery systems based on nanotechnology. The system is a microcontainers made from specially degradable biopolymers, which have the ability to attach to specified parts of the gastrointestinal tract and protect the active ingredient from the destructive action of proteolytic enzymes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Vosstaniya ulitsa 100
  • Kazan, 420095
  • Russia
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Izvarino Pharma
Vertical(s)
Nanotechnology, TMT
Corporate Office
  • Vosstaniya ulitsa 100
  • Kazan, 420095
  • Russia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanofarma Development Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanofarma Development‘s full profile, request access.

Request a free trial

Nanofarma Development Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nanofarma Development‘s full profile, request access.

Request a free trial

Nanofarma Development FAQs

  • When was Nanofarma Development founded?

    Nanofarma Development was founded in 2011.

  • Where is Nanofarma Development headquartered?

    Nanofarma Development is headquartered in Kazan, Russia.

  • What industry is Nanofarma Development in?

    Nanofarma Development’s primary industry is Drug Discovery.

  • Is Nanofarma Development a private or public company?

    Nanofarma Development is a Private company.

  • What is Nanofarma Development’s current revenue?

    The current revenue for Nanofarma Development is 000000.

  • Who are Nanofarma Development’s investors?

    Rusnano and Tatarstan Nanotechnologies Center have invested in Nanofarma Development.

  • When was Nanofarma Development acquired?

    Nanofarma Development was acquired on 14-Jan-2016.

  • Who acquired Nanofarma Development?

    Nanofarma Development was acquired by Izvarino Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »